Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viatris Inc.

10.17
+0.07000.69%
Post-market: 10.02-0.1516-1.49%19:55 EDT
Volume:5.51M
Turnover:55.91M
Market Cap:11.86B
PE:-3.48
High:10.20
Open:10.09
Low:10.07
Close:10.10
52wk High:13.55
52wk Low:6.85
Shares:1.17B
Float Shares:1.16B
Volume Ratio:0.74
T/O Rate:0.48%
Dividend:0.48
Dividend Rate:4.72%
EPS(TTM):-2.9198
EPS(LYR):-0.5315
ROE:-19.77%
ROA:2.30%
PB:0.76
PE(LYR):-19.14

Loading ...

Viatris Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Oct 17

QSM Asset Management Takes $11.5 Million Stake in Rio Tinto, Expands Energy Exposure

Motley Fool
·
Oct 17

QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market

Motley Fool
·
Oct 16

Viatris completes acquisition of Aculys Pharma

TIPRANKS
·
Oct 16

Press Release: Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia(R) in Japan and Certain Other Markets in the Asia-Pacific Region

Dow Jones
·
Oct 16

Viatris Initiated at Buy by Truist Securities

Dow Jones
·
Oct 15

Viatris initiated with a Buy at Truist

TIPRANKS
·
Oct 15

Viatris Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Oct 14

Viatris Inc. to Participate in UBS and Jefferies Global Healthcare Conferences

Reuters
·
Oct 13

Viatris Inc. Stock Falls Friday, Still Outperforms Market

Dow Jones
·
Oct 11

Viatris Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Oct 09

3 Cash-Producing Stocks We Keep Off Our Radar

stock_story_highlight
·
Oct 01

Viatris Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 30

Viatris Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Sep 26

Viatris Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 25

How Viatris’ (VTRS) Removal from the FTSE All-World Index Could Affect Investor Sentiment

Simply Wall St.
·
Sep 24

Viatris Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Sep 23

Viatris Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Sep 19

Mapi Pharma Announces First Patient Recruited in Phase-I/Ii Study of Cariprazine Depot Once Monthly Injection

THOMSON REUTERS
·
Sep 17

Viatris Inc. Stock Slips 3.6%, Underperforms Market

Dow Jones
·
Sep 16